Date: 2018-01-05
Type of information: Restructuring
Compound:
Company: Peregrine Pharmaceuticals, now Avid Bioservices (USA - CA)
Therapeutic area: Technology - Services
Type agreement: restructuring
Action mechanism:
Disease:
Details:
- • On January 5, 2018, Peregrine Pharmaceuticals announced that it is changing its name to Avid Bioservices as part of its transition to a dedicated contract development and manufacturing organization (CDMO). In addition to the name change, the company is also adopting the new NASDAQ ticker symbol "CDMO" . The name and ticker symbol changes will both be effective as of market open on Monday, January 8, 2018 .
Financial terms:
Latest news:
Is general: Yes
